{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:07:22Z","timestamp":1790838442217,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG044271"],"award-info":[{"award-number":["P30 AG044271"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 R01AG052697"],"award-info":[{"award-number":["R01 R01AG052697"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.clinthera.2019.01.006","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T01:30:57Z","timestamp":1551922257000},"page":"376-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Review of Interventions for the Frailty Syndrome and the Role of Metformin as a Potential Pharmacologic Agent for Frailty Prevention"],"prefix":"10.1016","volume":"41","author":[{"given":"Sara E.","family":"Espinoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozmin","family":"Jiwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-pin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2019.01.006_bib1","first-page":"1487","article-title":"Frailty and failure to thrive","volume":"5","author":"Fried","year":"2003","journal-title":"Princ Geriatr Med Gerontol"},{"key":"10.1016\/j.clinthera.2019.01.006_bib2","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J\u00a0Gerontol Ser A: Biol Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib3","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1111\/j.1532-5415.2012.04054.x","article-title":"Prevalence of frailty in community-dwelling older persons: a systematic review","volume":"60","author":"Collard","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib4","first-page":"262","article-title":"Phenotype of frailty: characterization in the women's health and aging studies","volume":"61","author":"Bandeen-Roche","year":"2006","journal-title":"J\u00a0Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib5","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1111\/j.1532-5415.2005.53405.x","article-title":"Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study","volume":"53","author":"Fugate Woods","year":"2005","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib6","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/j.1532-5415.2008.01845.x","article-title":"Frailty in older Mexican-American and European-American adults: is there an ethnic disparity?","volume":"56","author":"Espinoza","year":"2008","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib7","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archinternmed.2007.113","article-title":"Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women","volume":"168","author":"Ensrud","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib8","first-page":"722","article-title":"Frailty in relation to the accumulation of deficits","volume":"62","author":"Rockwood","year":"2007","journal-title":"J\u00a0Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib9","first-page":"738","article-title":"A\u00a0comparison of two approaches to measuring frailty in elderly people","volume":"62","author":"Rockwood","year":"2007","journal-title":"J\u00a0Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib10","series-title":"National Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States, 2014","year":"2014"},{"key":"10.1016\/j.clinthera.2019.01.006_bib11","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/jgs.12035","article-title":"Diabetes in older adults: a consensus report","volume":"60","author":"Kirkman","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/diab.40.1.44","article-title":"Age as independent determinant of glucose tolerance","volume":"40","author":"Shimokata","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2019.01.006_bib13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.clinthera.2019.01.006_bib14","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/dc09-0267","article-title":"Physical inactivity and obesity underlie the insulin resistance of aging","volume":"32","author":"Amati","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2019.01.006_bib15","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.2337\/db08-1198","article-title":"Adaptive \u03b2-cell proliferation is severely restricted with advanced age","volume":"58","author":"Rankin","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2019.01.006_bib16","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.2337\/db05-1586","article-title":"Aging correlates with decreased \u03b2-cell proliferative capacity and enhanced sensitivity to apoptosis: a potential role for Fas and pancreatic duodenal homeobox-1","volume":"55","author":"Maedler","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2019.01.006_bib17","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/dc07-1443","article-title":"Effect of aging on glucose homeostasis: accelerated deterioration of \u03b2-cell function in individuals with impaired glucose tolerance","volume":"31","author":"Szoke","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2019.01.006_bib18","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1532-5415.2005.53300.x","article-title":"The association between obesity and the frailty syndrome in older women: the Women's Health and Aging Studies","volume":"53","author":"Blaum","year":"2005","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib19","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1532-5415.2009.02196.x","article-title":"Is hyperglycemia associated with frailty status\u00a0in older women?","volume":"57","author":"Blaum","year":"2009","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib20","first-page":"1300","article-title":"Frailty status and altered glucose-insulin dynamics","volume":"67","author":"Kalyani","year":"2012","journal-title":"J\u00a0Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s12603-011-0134-1","article-title":"Physical frailty in older adults is associated with metabolic and atherosclerotic risk factors and cognitive impairment independent of muscle mass","volume":"15","author":"Lee","year":"2011","journal-title":"J\u00a0Nutr Health Aging"},{"key":"10.1016\/j.clinthera.2019.01.006_bib22","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/j.1532-5415.2011.03882.x","article-title":"Frailty transitions in the san Antonio longitudinal study of aging","volume":"60","author":"Espinoza","year":"2012","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib23","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.2337\/db05-1183","article-title":"Decreased muscle strength and quality in older adults with type 2 diabetes","volume":"55","author":"Park","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2019.01.006_bib24","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2337\/dc09-0264","article-title":"Excessive loss of skeletal muscle mass in older adults with type 2 diabetes","volume":"32","author":"Park","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2019.01.006_bib25","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2337\/dc06-2537","article-title":"Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the Health, Aging, and Body Composition Study","volume":"30","author":"Park","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2019.01.006_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2174\/138161208783497750","article-title":"Is there a relationship between insulin resistance and frailty syndrome?","volume":"14","author":"Abbatecola","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clinthera.2019.01.006_bib27","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/dc08-1781","article-title":"Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged\u2265 70 years","volume":"32","author":"Barzilay","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2019.01.006_bib28","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/archinte.167.7.635","article-title":"Insulin resistance and inflammation as precursors of frailty: the Cardiovascular Health Study","volume":"167","author":"Barzilay","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2318-9-49","article-title":"Inverse association between insulin resistance and gait speed in nondiabetic older men: results from the US National Health and Nutrition Examination Survey (NHANES) 1999-2002","volume":"9","author":"Kuo","year":"2009","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clinthera.2019.01.006_bib30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1532-5415.2011.03472.x","article-title":"Association between insulin resistance and lean mass loss and fat mass gain in older men without diabetes mellitus","volume":"59","author":"Lee","year":"2011","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.arr.2008.07.002","article-title":"Molecular inflammation: underpinnings of aging and age-related diseases","volume":"8","author":"Chung","year":"2009","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.clinthera.2019.01.006_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.arr.2010.11.002","article-title":"Inflammatory markers in population studies of aging","volume":"10","author":"Singh","year":"2011","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.clinthera.2019.01.006_bib33","first-page":"M242","article-title":"Inflammatory markers and physical performance in older persons: the InCHIANTI study","volume":"59","author":"Cesari","year":"2004","journal-title":"J\u00a0Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib34","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1532-5415.2004.52308.x","article-title":"Inflammatory markers and incident mobility limitation in the elderly","volume":"52","author":"Penninx","year":"2004","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib35","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.mad.2012.05.005","article-title":"Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study","volume":"133","author":"Collerton","year":"2012","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.clinthera.2019.01.006_bib36","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1001\/archinte.162.20.2333","article-title":"Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study","volume":"162","author":"Walston","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib37","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1532-5415.2007.01186.x","article-title":"Inflammation and frailty in older women","volume":"55","author":"Leng","year":"2007","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/gerona\/glr224","article-title":"Proteomic screening of glycoproteins in human plasma for frailty biomarkers","volume":"67","author":"Shamsi","year":"2012","journal-title":"J\u00a0Gerontol Ser A: Biol Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib39","first-page":"glt183","article-title":"Plasma protein biomarkers of the geriatric syndrome of frailty","author":"Darvin","year":"2013","journal-title":"J\u00a0Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0024-3205(00)00622-6","article-title":"Plasma interleukin-6, tumour necrosis factor \u03b1 and blood cytokine production in type 2 diabetes","volume":"67","author":"Pickup","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib41","doi-asserted-by":"crossref","first-page":"E794","DOI":"10.1152\/ajpendo.00776.2009","article-title":"NF-\u03baB activity in muscle from obese and type 2 diabetic subjects under basal and exercise-stimulated conditions","volume":"299","author":"Tantiwong","year":"2010","journal-title":"Am J Physiology Endocrinology Metab"},{"key":"10.1016\/j.clinthera.2019.01.006_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9149(03)00612-X","article-title":"Insulin resistance, inflammation, and the prediabetic state","volume":"92","author":"Haffner","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2019.01.006_bib43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2019.01.006_bib44","first-page":"114","article-title":"Pharmacological interventions in frailty and sarcopenia: report by the international conference on frailty and sarcopenia research task force","volume":"4","author":"Cesari","year":"2015","journal-title":"J\u00a0Frailty Aging"},{"key":"10.1016\/j.clinthera.2019.01.006_bib45","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199503023320902","article-title":"Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability","volume":"332","author":"Guralnik","year":"1995","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib46","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1001\/jama.2014.5616","article-title":"Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial","volume":"311","author":"Pahor","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2019.01.006_bib47","first-page":"216","article-title":"A\u00a0physical activity intervention to treat the frailty syndrome in older persons\u2014results from the LIFE-P study","volume":"70","author":"Cesari","year":"2014","journal-title":"J\u00a0Gerontol Ser A Biomed Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib48","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7326\/M16-2011","article-title":"Effect of physical activity on frailty: secondary analysis of a randomized controlled trial","volume":"168","author":"Trombetti","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib49","first-page":"401","article-title":"Effectiveness of an intervention to prevent frailty in pre-frail community-dwelling older people consulting in primary care: a randomised controlled trial","volume":"46","author":"Serra-Prat","year":"2017","journal-title":"Age Ageing"},{"key":"10.1016\/j.clinthera.2019.01.006_bib50","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1046\/j.1532-5415.2002.50601.x","article-title":"Effects of exercise training on frailty in community-dwelling older adults: results of a randomized, controlled trial","volume":"50","author":"Binder","year":"2002","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib51","first-page":"M350","article-title":"Physical and performance measures for the identification of mild to moderate frailty","volume":"55","author":"Brown","year":"2000","journal-title":"J\u00a0Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib52","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJMoa1008234","article-title":"Weight loss, exercise, or both and physical function in obese older adults","volume":"364","author":"Villareal","year":"2011","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib53","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ijo.2013.122","article-title":"Weight loss, exercise or both and cardiometabolic risk factors in obese older adults: results of a randomized controlled trial","volume":"38","author":"Bouchonville","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/j.clinthera.2019.01.006_bib54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apmr.2011.08.042","article-title":"Effect of exercise on physical function, daily living activities, and quality of life in the frail older adults: a meta-analysis","volume":"93","author":"Chou","year":"2012","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.clinthera.2019.01.006_bib55","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12877-015-0155-4","article-title":"Effects of physical exercise interventions in frail older adults: a systematic review of randomized controlled trials","volume":"15","author":"de Labra","year":"2015","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.clinthera.2019.01.006_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cger.2010.08.001","article-title":"Exercise as an intervention for frailty","volume":"27","author":"Liu","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib57","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-007091","article-title":"Effectiveness of a multifactorial intervention on preventing development of frailty in pre-frail older people: study protocol for a randomised controlled trial","volume":"5","author":"Fairhall","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinthera.2019.01.006_bib58","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1741-7015-11-65","article-title":"A\u00a0multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial","volume":"11","author":"Cameron","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib59","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2105\/AJPH.90.6.947","article-title":"Dietary supplements and physical exercise affecting bone and body composition in frail elderly persons","volume":"90","author":"de Jong","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.clinthera.2019.01.006_bib60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/gerona\/glx141","article-title":"Nutritional supplementation with physical activity improves muscle composition in mobility-limited older adults, the VIVE2 study: a randomized, double-blind, placebo-controlled trial","volume":"73","author":"Englund","year":"2018","journal-title":"J\u00a0Gerontol Ser A"},{"key":"10.1016\/j.clinthera.2019.01.006_bib61","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s12603-017-0936-x","article-title":"Effect of structured physical activity and nutritional supplementation on physical function in mobility-limited older adults: results from the VIVE2 randomized trial","volume":"21","author":"Fielding","year":"2017","journal-title":"J\u00a0Nutr Health Aging"},{"key":"10.1016\/j.clinthera.2019.01.006_bib62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cct.2015.06.001","article-title":"The vitality, independence, and vigor in the Elderly 2 Study (VIVE2): design and methods","volume":"43","author":"Kirn","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.clinthera.2019.01.006_bib63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0749-3797(03)00022-9","article-title":"Can primary care doctors prescribe exercise to improve fitness?: the Step Test Exercise Prescription (STEP) project","volume":"24","author":"Petrella","year":"2003","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib64","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.amepre.2005.06.016","article-title":"Randomized controlled trial of physical activity counseling for older primary care patients","volume":"29","author":"Pinto","year":"2005","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib65","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nature08221","article-title":"Rapamycin fed late in life extends lifespan in genetically heterogeneous mice","volume":"460","author":"Harrison","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2019.01.006_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exger.2012.11.014","article-title":"Translating advances from the basic biology of aging into clinical application","volume":"48","author":"Kirkland","year":"2013","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.clinthera.2019.01.006_bib67","first-page":"1424","article-title":"Strategies and challenges in clinical trials targeting human aging","volume":"71","author":"Newman","year":"2016","journal-title":"J\u00a0Gerontol Ser A Biomed Sci Med Sci"},{"key":"10.1016\/j.clinthera.2019.01.006_bib68","doi-asserted-by":"crossref","first-page":"150","DOI":"10.14283\/jfa.2018.20","article-title":"Designing drug trials for frailty: ICFSR Task Force 2018","volume":"7","author":"Pahor","year":"2018","journal-title":"J\u00a0Frailty Aging"},{"key":"10.1016\/j.clinthera.2019.01.006_bib69","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/jgs.14965","article-title":"ENabling reduction of low-grade inflammation in SEniors pilot study: concept, rationale, and design","volume":"65","author":"Manini","year":"2017","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2019.01.006_bib70","first-page":"S14","article-title":"Standards of medical care in diabetes\u20142014","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2019.01.006_bib71","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.2337\/diacare.25.8.1410","article-title":"Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes?: UK prospective diabetes study 61","volume":"25","author":"Colagiuri","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2019.01.006_bib72","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib73","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1464-5491.2005.01632.x","article-title":"Metformin reduces C\u2013reactive protein but not complement factor C3 in overweight patients with type 2 diabetes mellitus","volume":"22","author":"Carter","year":"2005","journal-title":"Diabetic Med"},{"key":"10.1016\/j.clinthera.2019.01.006_bib74","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/ncomms3192","article-title":"Metformin improves healthspan and lifespan in mice","volume":"4","author":"Martin-Montalvo","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2019.01.006_bib75","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.clinthera.2019.01.006_bib76","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2337\/diabetes.51.7.2074","article-title":"Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes","volume":"51","author":"Musi","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2019.01.006_bib77","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cmet.2016.05.011","article-title":"Metformin as a tool to target aging","volume":"23","author":"Barzilai","year":"2016","journal-title":"Cel Metab"},{"key":"10.1016\/j.clinthera.2019.01.006_bib78","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1111\/bph.12585","article-title":"Metformin induces PGC-1\u03b1 expression and selectively affects hepatic PGC-1\u03b1 functions","volume":"171","author":"Aatsinki","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinthera.2019.01.006_bib79","article-title":"Frailty attenuates the impact of metformin on reducing mortality in older adults with type 2 diabetes","volume":"2","author":"Wang","year":"2014","journal-title":"J\u00a0Endocrinol Diabetes Obes"},{"key":"10.1016\/j.clinthera.2019.01.006_bib80","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.arr.2017.08.003","article-title":"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: a systematic review and meta-analysis","volume":"40","author":"Campbell","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.clinthera.2019.01.006_bib81","doi-asserted-by":"crossref","DOI":"10.2337\/dc11-1032","article-title":"Insulin sensitizers may attenuate lean mass loss in older men with diabetes","author":"Lee","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2019.01.006_bib82","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1111\/jgs.12502","article-title":"Changes in physical performance in older women according to presence and treatment of diabetes mellitus","volume":"61","author":"Lee","year":"2013","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2019.01.006_bib83","series-title":"Adults Need More Physical Activity","year":"2018"},{"key":"10.1016\/j.clinthera.2019.01.006_bib84","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ypmed.2004.04.003","article-title":"Barriers and motivations to exercise in older adults","volume":"39","author":"Schutzer","year":"2004","journal-title":"Prev Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819300104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819300104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:50:04Z","timestamp":1758963004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819300104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0149291819300104"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.01.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of Interventions for the Frailty Syndrome and the Role of Metformin as a Potential Pharmacologic Agent for Frailty Prevention","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}